NEW YORK (GenomeWeb News) – Molecular diagnostics firm QuantuMDx said today it has bought identity testing company NorthGene in a stock and cash deal for an undisclosed amount.

Founded in 1995 as a spin-out of Newcastle University in the UK, NorthGene provides paternity and other relationship testing. QuantuMDx said that it plans to build out NorthGene's laboratory and staffing infrastructure, secure laboratory accreditation, and expand its test portfolio and DNA analysis services "to embrace medical, veterinary, and scientific research application."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.